TW200616628A - Pharmaceutical composition for xerophthalmia and xerostomia treatment - Google Patents
Pharmaceutical composition for xerophthalmia and xerostomia treatmentInfo
- Publication number
- TW200616628A TW200616628A TW094134706A TW94134706A TW200616628A TW 200616628 A TW200616628 A TW 200616628A TW 094134706 A TW094134706 A TW 094134706A TW 94134706 A TW94134706 A TW 94134706A TW 200616628 A TW200616628 A TW 200616628A
- Authority
- TW
- Taiwan
- Prior art keywords
- xerophthalmia
- pharmaceutical composition
- xerostomia
- xerostomia treatment
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004292611 | 2004-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200616628A true TW200616628A (en) | 2006-06-01 |
Family
ID=36142669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094134706A TW200616628A (en) | 2004-10-05 | 2005-10-04 | Pharmaceutical composition for xerophthalmia and xerostomia treatment |
Country Status (15)
Country | Link |
---|---|
US (2) | US20070105934A1 (zh) |
EP (1) | EP1712230A1 (zh) |
JP (1) | JPWO2006038596A1 (zh) |
KR (1) | KR20070061578A (zh) |
CN (1) | CN101031297A (zh) |
AU (1) | AU2005290532A1 (zh) |
BR (1) | BRPI0516468A (zh) |
CA (1) | CA2582615A1 (zh) |
IL (1) | IL182124A0 (zh) |
MX (1) | MX2007003994A (zh) |
NO (1) | NO20072328L (zh) |
RU (1) | RU2007116944A (zh) |
TW (1) | TW200616628A (zh) |
WO (1) | WO2006038596A1 (zh) |
ZA (1) | ZA200702784B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090082381A1 (en) * | 2005-07-26 | 2009-03-26 | Akiharu Isowaki | Percutaneously Absorbable Ophthalmic Preparation |
US10338203B2 (en) | 2011-09-09 | 2019-07-02 | Siemens Medical Solutions Usa, Inc. | Classification preprocessing in medical ultrasound shear wave imaging |
JP6526475B2 (ja) * | 2015-04-30 | 2019-06-05 | サンスター株式会社 | 経皮唾液腺投与用の唾液分泌促進剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2683783B2 (ja) * | 1992-07-10 | 1997-12-03 | 雪印乳業株式会社 | シェーグレン症候群治療剤 |
ATE219933T1 (de) * | 1992-09-18 | 2002-07-15 | Yamanouchi Pharma Co Ltd | Hydrogelzubereitung mit verzögerter freisetzung |
JPH07126163A (ja) * | 1993-10-08 | 1995-05-16 | Theratech Inc | 制御放出性ピロカルピン送達システム |
US6528529B1 (en) * | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
US20020142033A1 (en) * | 1998-05-05 | 2002-10-03 | Gupta Suneel K. | Method for treating incontinence |
US20020028240A1 (en) * | 2000-04-17 | 2002-03-07 | Toyohiro Sawada | Timed-release compression-coated solid composition for oral administration |
JP2003063964A (ja) * | 2001-08-28 | 2003-03-05 | Senju Pharmaceut Co Ltd | ドライアイまたはドライアイを伴なう疾病の予防治療剤 |
-
2005
- 2005-10-04 RU RU2007116944/15A patent/RU2007116944A/ru not_active Application Discontinuation
- 2005-10-04 TW TW094134706A patent/TW200616628A/zh unknown
- 2005-10-04 CA CA002582615A patent/CA2582615A1/en not_active Abandoned
- 2005-10-04 US US10/578,682 patent/US20070105934A1/en not_active Abandoned
- 2005-10-04 ZA ZA200702784A patent/ZA200702784B/xx unknown
- 2005-10-04 MX MX2007003994A patent/MX2007003994A/es not_active Application Discontinuation
- 2005-10-04 BR BRPI0516468-0A patent/BRPI0516468A/pt not_active IP Right Cessation
- 2005-10-04 WO PCT/JP2005/018310 patent/WO2006038596A1/ja active Application Filing
- 2005-10-04 AU AU2005290532A patent/AU2005290532A1/en not_active Abandoned
- 2005-10-04 EP EP05790491A patent/EP1712230A1/en not_active Withdrawn
- 2005-10-04 KR KR1020077010162A patent/KR20070061578A/ko not_active Application Discontinuation
- 2005-10-04 CN CNA2005800329427A patent/CN101031297A/zh active Pending
- 2005-10-04 JP JP2006539287A patent/JPWO2006038596A1/ja not_active Withdrawn
-
2007
- 2007-03-22 IL IL182124A patent/IL182124A0/en unknown
- 2007-05-04 NO NO20072328A patent/NO20072328L/no not_active Application Discontinuation
- 2007-09-26 US US11/861,725 patent/US20080131511A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101031297A (zh) | 2007-09-05 |
US20070105934A1 (en) | 2007-05-10 |
US20080131511A1 (en) | 2008-06-05 |
EP1712230A1 (en) | 2006-10-18 |
AU2005290532A1 (en) | 2006-04-13 |
NO20072328L (no) | 2007-06-29 |
MX2007003994A (es) | 2007-06-15 |
KR20070061578A (ko) | 2007-06-13 |
CA2582615A1 (en) | 2006-04-13 |
ZA200702784B (en) | 2008-09-25 |
WO2006038596A1 (ja) | 2006-04-13 |
RU2007116944A (ru) | 2008-11-20 |
BRPI0516468A (pt) | 2008-09-09 |
IL182124A0 (en) | 2007-07-24 |
JPWO2006038596A1 (ja) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20125565B (en) | Lactam compounds and their pharmaceutical use | |
UA95975C2 (ru) | N-метиламинометилизоиндольные соединения, композиции, содержащие их, и способы их применения | |
HK1076605A1 (en) | Formulations | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
TW200626132A (en) | Topical nepafenac formulations | |
GB0625648D0 (en) | Compounds | |
MX2009007104A (es) | Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina. | |
TW200716546A (en) | Oxindole compounds and their uses as therapeutic agents | |
MA29662B1 (fr) | Compositions pour l'apport de medicaments hautement solubles dans l'eau | |
JO2701B1 (en) | Vehicles | |
GEP20074197B (en) | 5ht2c receptor modulators | |
MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
TW200611695A (en) | Pyrrolopyridine derivatives | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
WO2005002515A3 (en) | Delivery of therapeutic compounds to the brain and other tissues | |
MX2009007337A (es) | Indazoles sustituidos con 5-piridinona. | |
TW200621244A (en) | Modulators of muscarinic receptors | |
MX2007006382A (es) | Moduladores de receptores muscarinicos. | |
GB2446341A (en) | Method and system for transdermal drug delivery | |
TW200531686A (en) | Pharmaceutical compositions | |
UA91694C2 (ru) | Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций | |
TW200616628A (en) | Pharmaceutical composition for xerophthalmia and xerostomia treatment | |
MXPA05003718A (es) | Compuestos x-nitro, sus composiciones farmaceuticas y sus usos. | |
UA91988C2 (ru) | Фармацевтическая композиция на основе антагонистов nk2 для применения в педиатрии |